Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Aznar

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2011
A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine(®) , a high-purity factor IX concentrate, in patients with severe haemophilia BT Lissitchkov, M Matysiak, K Zavilska, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 13, 2009
Haemophilia in SpainJ A Aznar, F Lucía, L Abad-Franch, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1985
A study of lymphocyte populations and subpopulations in hemophiliacs and their relationships with age and consumption of lyophilized factor VIII concentratesJ A Aznar, F Carbonell, J I Jorquera, et al.
Sangre|January 1, 1985
[Lymphocyte T population in hemophilia A and its relation with factor VIII therapy and the presence of HBsAg or anti-F.VIII:C inhibitors]J A Aznar, F Carbonell, J I Jorquera, et al.
Thrombosis and Haemostasis|October 31, 1984
Immunological studies of haemophilic patients with inhibitors treated with Factor VIII concentrates in a protocol to induce immunotoleranceJ A Aznar, J I Jorquera, F Carbonell, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 28, 2012
Is on-demand treatment effective in patients with severe haemophilia?J A Aznar, A Marco, V Jiménez-Yuste, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2013
Head-to-head comparison of the pharmacokinetic profiles of a high-purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia BT Lissitchkov, M Matysiak, K Zavilska, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 13, 2010
Focusing on haemophilia B: prophylaxis in Spanish patientsJ A Aznar, J F Lucia, L Abad-Franch, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 13, 2010
Prophylaxis therapy in haemophilia A: current situation in SpainJ F Lucía, J A Aznar, L Abad-Franch, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 9, 2011
Joint protection in haemophiliaE C Rodriguez-Merchan, V Jimenez-Yuste, J A Aznar, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2011
A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine(®) , a high-purity factor IX concentrate, in patients with severe haemophilia BT Lissitchkov, M Matysiak, K Zavilska, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 13, 2009
Haemophilia in SpainJ A Aznar, F Lucía, L Abad-Franch, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1985
A study of lymphocyte populations and subpopulations in hemophiliacs and their relationships with age and consumption of lyophilized factor VIII concentratesJ A Aznar, F Carbonell, J I Jorquera, et al.
Sangre|January 1, 1985
[Lymphocyte T population in hemophilia A and its relation with factor VIII therapy and the presence of HBsAg or anti-F.VIII:C inhibitors]J A Aznar, F Carbonell, J I Jorquera, et al.
Thrombosis and Haemostasis|October 31, 1984
Immunological studies of haemophilic patients with inhibitors treated with Factor VIII concentrates in a protocol to induce immunotoleranceJ A Aznar, J I Jorquera, F Carbonell, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 28, 2012
Is on-demand treatment effective in patients with severe haemophilia?J A Aznar, A Marco, V Jiménez-Yuste, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2013
Head-to-head comparison of the pharmacokinetic profiles of a high-purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia BT Lissitchkov, M Matysiak, K Zavilska, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 13, 2010
Focusing on haemophilia B: prophylaxis in Spanish patientsJ A Aznar, J F Lucia, L Abad-Franch, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 13, 2010
Prophylaxis therapy in haemophilia A: current situation in SpainJ F Lucía, J A Aznar, L Abad-Franch, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 9, 2011
Joint protection in haemophiliaE C Rodriguez-Merchan, V Jimenez-Yuste, J A Aznar, et al.
Pageof 12